Perception and attitude of general practitioners regarding generic medicines in Karachi, Pakistan: A questionnaire based study

Southern Med Review

Volumn 5, Issue 1, 2012, Pages 22-30

  Jamshed, Shazia Qasim ^a   Ibrahim, Mohamed Izham Mohamed ^b   Hassali, Mohamed Azmi Ahmad ^c   Masood, Imran ^c   Low, Bee Yean ^d   Shafie, Asrul Akmal ^c   Babar, Zaheer ud din ^e  

^a INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^b College of Pharmacy ^*  (Qatar)

^c SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^d UNIVERSITY OF NOTTINGHAM MALAYSIA CAMPUS   (Malaysia)

^e UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Attitude; Dispensing doctor; General practitioner; Generic medicines; Karachi; Pakistan; Perception

Indexed keywords

GENERIC DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENERAL PRACTITIONER; HUMAN; INFORMATION DISSEMINATION; MALE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; PAKISTAN; PHYSICIAN ATTITUDE; PRESCRIPTION; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE; WORK EXPERIENCE;

EID: 84864370569     PISSN: 11742704     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Eichenholz J. Trends in Managed care pharmacy; preparing for the future. Journal of Managed Care Pharmacy. 2001;7(2):105-10.
2. The World Medicines Situation WHO/EDM/PAR/2004.5. Geneva: World Health Organization Available from www.searo.who.int/.../Reports_World_Medicines_Situation.pdf (2004).
3. Pakistan Pharmaceutical and Healthcare Report Q3 2011. BMI Industry Report and Forecast Series Business Monitor International, (2011).
4. Kiani AG. The price conundrum. Dawn Available at http://dawncom/2012/06/08/the-price-conundrum/ Accessed on 9th July, 2012. 2012.
5. Karim SA, Pillai G, Ziqubu-Page TT, Cassimjee MH, Morar MS. Potential savings from generic prescribing and generic substitution in South Africa. Health Policy Plan. 1996 July 1, 1996;11(2):198-202.
6. Carroll NV. Financial impact of generic and therapeutic interchange incentives on community pharmacy. American Pharmacy. 1995;NS35:27-34.
7. Anonymous. Government wants sale of drugs under generic names 2007. The Dawn Internet Edition [Online} Available on World Wide Web: http://wwwdawncom/2007/10/25/local17htm, Accessed 25th May 2012.
8. Quraeshi ZA, Luqmani M, Malhotra N. Brands or Generics: the dilemma of pharmaceutical marketing in a developing country. Journal of Health Care Marketing. 1983;3(4):27-37.
9. Pakistan Pharmaceutical and Healthcare Report Q1 2010. BMI Industry Report and Forecast Series Business Monitor International, (2010).
10. Pakistan Pharmaceutical Industry. Pakistan Pharmaceutical Manufacturers Association [Online] [Accessed at February 2010] Available on the World Wide Web: http://www.ppma.org.pk/PPMAIndustry.aspx (2007).
11. Use of drugs in Sind Province Pakistan primary health care facilities, (2001).
12. Jamshed SQ, Ibrahim MIM, Hassali MA. Icebreakers-Unexpected Outcomes. Journal of College of Physicians and Surgeons. 2010;20(2):142.
13. Hassali MA, Shafie AA, Awaisu A, Ibrahim MI, Ping CC, Jamshed S. Physicians/' views on generic medicines: A narrative review. J Generic Med. 2009;7(1):30-9.
14. Nizami SQ, Khan IA, Bhutta ZA. Drug prescribing practices of general practitioners and paediatricians for childhood diarrhoea in Karachi, Pakistan. Social Science & Medicine. 1996;42(8):1133-9.
15. Jamshed SQ, Hassali MA, Ibrahim MIM, Babar ZuD. Knowledge attitude and perception of dispensing doctors regarding generic medicines in Karachi, Pakistan: A qualitative study. Journal of Pakistan Medical Association. 2011;61(1):80-3.
16. Asch DA, Jedrziewski MK, Christakis NA. Response rates to mail surveys published in medical journals. Journal of Clinical Epidemiology. 1997;50(10):1129-36.
17. Scott EK, Joan H. Physician response to surveys: A review of the literature. American journal of preventive medicine. 2001;20(1):61-7.
18. Hassali MA, Kong DCM, Stewart K. Generic medicines: Perceptions of general practitioners in Melbourne, Australia. Journal of Generic medicine. 2006;3(3):214-25.
19. Sharrad AK, Hassali MA, Shafie AA. Generic medicines: Perceptions of Physicians in Basrah, Iraq. Australasian Medical Journal. 2009;1(8):58-64.
20. Chua GN, Hassali MA, Shafie AA, Awaisu A. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy. 2010;95(2-3):229-35.
21. Pakistan Country Profile World Health Organization Available on World Wide Web:. http://www.who.int/countries/pak/en/ Accessed 8th July, 2012, (2005).
22. Shrank WH, Liberman JN, Fischer MA, Girdish C, Brennan TA, Choudhry NK. Physician perceptions about generic drugs. Ann Pharmacother. 2011 January 4, 2011;45:aph.1P389.
23. Kingman S. Fisons investigations of excessive hospitality. British Medical Journal. 1993;307:1301-2.
24. Kersnik J, Peklar J. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies. Journal of Clinical Pharmacy and Therapeutics. 2006;31:577-83.
25. Hsu Y-H, Fang W, Lee Y. Ethically questionable behavior in sales representatives - An example from the Taiwanese pharmaceutical industry. Journal of Business Ethics. 2009;88(0):155-66.
26. Komesaroff PA, Kerridge IH. Ethical issues concerning the relationships between medical practitioners and the pharmaceutical industry. Medical Journal of Australia. 2002;176:118-21.
27. Prosser H, Almond S, Walley T. Influences on GPs' decision to prescribe new drugs--the importance of who says what. Fam Pract. 2003 February 1, 2003;20(1):61-8.
28. Caudill TS, Johnson MS, Rich EC, McKinney WP. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch Fam Med. 1996 April 1, 1996;5(4):201-6.
29. Rohra DK, Gilani AH, Memon IK, Perven G, Khan MT, Zafar H, et al. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan. J Pharm Pharm Sci. 2006;9(1):50-9.
30. Carthy P, Harvey I, Brawn R, Watkins C. A study of factors associated with cost and variation in prescribing among GPs. Fam Pract. 2000 February 1, 2000;17(1):36-41.
31. Friedman M. The social responsibility of business is to increase its profit. The New York Times Magazine. 1970.
32. Peay ER, Peay MY. Differences among practitioners in patterns of preference for information sources in the adoption of new drugs. Social Science & Medicine. 1984;18(12):1019-25.
33. Andersson SJ, Lindberg G, Troein M. What shapes GPsâ ™ work with depressed patients? A qualitative interview study. Family Practice. 2002 December 1, 2002;19(6):623-31.
34. Glickman L, Bruce EA, Caro FG, Avorn J. Physicians' knowledge of drug costs for the elderly. J Am Geriatr Soc. 1994;42(9):992-6.
35. McGuire C, King S, Roche-Nagle G, Barry M. Doctors' attitudes about prescribing and knowledge of the costs of common medications. Irish Journal of Medical Science. 2009;178(3):277-80.
36. Howell E. Prescribing patterns drive up health care costs. CMAJ. 2007 December 4, 2007;177(12):1487.
37. Cooke M. Cost Consciousness in Patient Care -- What Is Medical Education's Responsibility? N Engl J Med. April 8, 2010;362(14):1253-5.